<SEC-DOCUMENT>0001493152-24-035636.txt : 20240910
<SEC-HEADER>0001493152-24-035636.hdr.sgml : 20240910
<ACCEPTANCE-DATETIME>20240910163013
ACCESSION NUMBER:		0001493152-24-035636
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20240910
DATE AS OF CHANGE:		20240910

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CareCloud, Inc.
		CENTRAL INDEX KEY:			0001582982
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-PREPACKAGED SOFTWARE [7372]
		ORGANIZATION NAME:           	06 Technology
		IRS NUMBER:				223832302
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36529
		FILM NUMBER:		241290419

	BUSINESS ADDRESS:	
		STREET 1:		7 CLYDE ROAD
		STREET 2:		SOMERSET
		CITY:			SOMERSET
		STATE:			NJ
		ZIP:			08873
		BUSINESS PHONE:		7328735133

	MAIL ADDRESS:	
		STREET 1:		7 CLYDE ROAD
		STREET 2:		SOMERSET
		CITY:			SOMERSET
		STATE:			NJ
		ZIP:			08873

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MTBC, Inc.
		DATE OF NAME CHANGE:	20190206

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MEDICAL TRANSCRIPTION BILLING, CORP
		DATE OF NAME CHANGE:	20130731
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>formdefa14a.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>WASHINGTON,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SCHEDULE
14A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proxy
Statement Pursuant to Section 14(a) of the Securities</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exchange
Act of 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
by the Registrant &#9746;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
by a Party other than the Registrant &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preliminary
    Proxy Statement</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONFIDENTIAL,
    FOR USE OF THE COMMISSION ONLY (AS PERMITTED BY RULE 14a-6(e)(2))</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitive
    Proxy Statement</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9746;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitive
    Additional Materials</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    Material under &sect; 240.14a-12</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>CareCloud,
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name
of Registrant as Specified In Its Charter)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name
of Person(s) Filing Proxy Statement, if other than the Registrant)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
of Filing Fee (Check all boxes that apply):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    fee required.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee
    paid previously with preliminary materials.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee
    computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; border-bottom: Black 4pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><IMG SRC="defa14a_001.jpg" ALT="" STYLE="width: 200px"></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>99%
of Required Votes Obtained for CareCloud&rsquo;s Series A Preferred Stock Proposal, Proxy Vote Solicitation Continues</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SOMERSET,
N.J., September 10, 2024 (GLOBE NEWSWIRE) &mdash;</B> <U>CareCloud, Inc.</U> (the &ldquo;Company&rdquo;) (Nasdaq: CCLD, CCLDO, CCLDP),
a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced that while proxy vote
solicitation continues, it has already obtained approximately 99% of the minimum required &ldquo;FOR&rdquo; votes by proxy in support
of the amendment to the Company&rsquo;s Certificate of Designations, Preferences and Rights of its Series A Preferred Stock (the &ldquo;Preferred
Stock Proposal&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of today, the Company has supportive proxy indications from more than 2.97 million shares and believes that it is quickly approaching
the required 3.02 million share threshold. Additional investors who wish to submit their voting instructions can do so now by calling
844-874-6164, by visiting <U>www.aalvote.com/ccld</U>, or by mailing back their completed proxy card received from CareCloud. Anyone
who would rather attend the Special Meeting in person can do so by following the instructions contained in the Definitive Proxy materials.
While the Special Meeting is presently scheduled for September 11, 2024, the Company may adjourn the meeting if it needs additional time
to continue vote solicitation activities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Preferred Stock Proposal is ultimately approved, holders of Series A Preferred Stock would receive similar change of control protections
to those afforded to holders of the Company&rsquo;s Series B 8.75% Cumulative Redeemable Perpetual Preferred Stock (the &ldquo;Series
B Preferred Stock&rdquo;). Also, the dividend of Series A Preferred Stock would mirror that of the Series B Preferred Stock, and the
Company would, going forward, have the right to exchange the shares of Series A Preferred Stock for common stock at the liquidation preference
value of $25/share, plus accrued and unpaid dividends.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company, while optimistic, cannot predict future proxy or voting results, which could be more or less favorable than the trends seen
to date. Those who have already returned proxy vote indications have the ability to change their instructions. Any shares that are not
voted will be deemed &ldquo;no&rdquo; votes for the Preferred Stock Proposal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information contained in this press release is a summary of certain relevant portions of the Definitive Proxy Statement and other materials
filed with the SEC. It is important that Series A Preferred Shareholders review the entirety of the filings, which are available on the
SEC&rsquo;s website and on <U>https://ir.carecloud.com/series-a-special-proxy</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">About
CareCloud</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CareCloud
brings disciplined innovation to the business of healthcare. Our suite of technology-enabled solutions helps clients increase financial
and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers count on CareCloud
to help them improve patient care while reducing administrative burdens and operating costs. Learn more about our products and services
including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience
management (PXM) and digital health at <U>www.carecloud.com</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Follow
CareCloud on <U>LinkedIn</U>, X and <U>Facebook.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Important
Additional Information and Where To Find It.</B> CareCloud filed with the SEC a definitive proxy statement on Schedule 14A on July 8,
2024, with respect to its future solicitation of proxies for the Special Meeting of Series A Preferred Stock shareholders (including
any and all adjournments, postponements, continuations, and reschedulings thereof, the &ldquo;Special Meeting&rdquo;). The information
contained in this press release is merely a summary of certain relevant portions of the Proxy Statement and it is important that Series
A Preferred Stock shareholders review the entirety of the filing. <B>SERIES A PREFERRED STOCK SHAREHOLDERS ARE URGED TO READ THE DEFINITIVE
PROXY STATEMENT AND ANY OTHER AMENDMENTS OR SUPPLEMENTS FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN OR WILL
CONTAIN IMPORTANT INFORMATION ABOUT CARECLOUD&rsquo;S FILING</B>. Investors and security holders may obtain copies of these documents
and other documents filed with the SEC by CareCloud free of charge through the website maintained by the SEC at <U>www.sec.gov</U>. The
Notice of the Special Meeting of Series A Preferred Stockholders and our Proxy Statement for the Special Meeting, the Annual Report on
Form 10-K for the fiscal year ended December 31, 2023 and our Quarterly Reports on Form 10-Q for the quarterly periods ended March 31,
2024 and June 30, 2024 are available at <U>www.sec.gov</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forward-Looking
Statements</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release contains various forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities
Litigation Reform Act of 1995. These statements relate to anticipated future events, future results of operations or future financial
performance. In some cases, you can identify forward-looking statements by terminology such as &ldquo;may,&rdquo; &ldquo;might,&rdquo;
&ldquo;will,&rdquo; &ldquo;shall,&rdquo; &ldquo;should,&rdquo; &ldquo;could&rdquo;, &ldquo;intends,&rdquo; &ldquo;expects,&rdquo; &ldquo;plans,&rdquo;
&ldquo;goals,&rdquo; &ldquo;projects,&rdquo; &ldquo;anticipates,&rdquo; &ldquo;believes,&rdquo; &ldquo;seeks,&rdquo; &ldquo;estimates,&rdquo;
&ldquo;predicts,&rdquo; &ldquo;possible,&rdquo; &ldquo;potential,&rdquo; &ldquo;target,&rdquo; or &ldquo;continue&rdquo; or the negative
of these terms or other comparable terminology.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could
materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Forward-looking
statements in this press release include, without limitation, statements reflecting management&rsquo;s expectations for future financial
performance and operating expenditures, expected growth, profitability and business outlook, the impact of pandemics on our financial
performance and business activities, and the expected results from the integration of our acquisitions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are only predictions, are
uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our (or our industry&rsquo;s)
actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance
expressed or implied by these forward-looking statements. We do not have an ongoing obligation to update shareholders regarding future
proxy or vote trends, even if they are materially different from those experienced to date. New risks and uncertainties emerge from time
to time, and it is not possible for us to predict all of the risks and uncertainties that could have an impact on the forward-looking
statements, including without limitation, risks and uncertainties relating to the Company&rsquo;s ability to manage growth, migrate newly
acquired customers and retain new and existing customers, maintain cost-effective global operations, increase operational efficiency
and reduce operating costs, predict and properly adjust to changes in reimbursement and other industry regulations and trends, retain
the services of key personnel, develop new technologies, upgrade and adapt legacy and acquired technologies to work with evolving industry
standards, compete with other companies products and services competitive with ours, and other important risks and uncertainties referenced
and discussed under the heading titled &ldquo;Risk Factors&rdquo; in the Company&rsquo;s filings with the Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on
its website or otherwise. The Company does not assume any obligations to update the forward-looking statements provided to reflect events
that occur or circumstances that exist after the date on which they were made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SOURCE
CareCloud</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
Contact:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Norman
Roth</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interim
Chief Financial Officer and Corporate Controller</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CareCloud,
Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>nroth@carecloud.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investor
Contact:</B> Bill Korn</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CareCloud,
Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>ir@carecloud.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>defa14a_001.jpg
<TEXT>
begin 644 defa14a_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #9 T,# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IDLT<$32RNJ1J,LS'
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M*  @$8(R*XOQ3X(M;^.6]LML%PH+,O16P/TKM*QO%=P]KX9O94.&V;1^)Q_6
MNC#5*D*J]F[-G'C:5*I1E[57239X?M._;CG.*]4\&>$(;&VCU"^C#W,@W(C#
M(C'^-<!X9M%O_$=E!(,HT@+?05[H   !T%>SFF(E!*E'KN?.Y'@X5&Z\U>VB
M"BBBOGCZXYGQ3X3MM:M'FA18[U!E6 QO]C7E-E=W.BZJDR92:%^5/MU!KWRO
M'?']FEKXGE9%P)460_4]:]S+*[E>A/56/F,[PL8)8FGH[Z_HSUFPO8[^P@ND
M(VRH&%%>06'BFXLK&*V5CMC&!S16,LLJ<SML=$,[H\JYMSVBBBBO)/?"BBN?
MUSQAINB9C9_/N!_RRC/3ZGM6E.G.I+E@KLRJUJ=&//4=D=!44UQ#;KF:5(QZ
MLV*\DU3Q[J]\S+#(+:/IMCZX^M<W)=W,Y)DFD<GKN8FO5IY3-ZSE;\3P:V?T
MHNU*+?X'N+^(='C.&U*V!_ZZ"F)XGT1S@:E;_B^*\, <G S^%!#@X^:NG^R*
M?\S_  .)\05OY%^)] V]_:77_'O<Q2_[C U8KYXCGFA.8Y'0_P"R<5T6D^.-
M6TTA6E^T1#C9+S^M<]7*9+6G*YUT<_A)VJQMYK4]EHKG=!\8:=K86/=Y%SC_
M %;GK]#WKHJ\FI3G3ERS5F?04JU.M'GINZ"BBBLS4**** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBFNZQH7=
M@JCDDG % #J*XO6_B%96.^&P7[3,,C?T0'^M<%J7BG5M48^==NJ9R$0[0*]*
MAEM:IJ]%YGC8G.</1?+'WGY?YGLMQJVGVIQ/>P1GT9P*I-XKT-#@ZC"?HU>(
M-*[G+,2?4FF[CZFN^.40ZR9Y,N(*M_=@OQ/=HO$>CS'":C;D^F\"M&*:*=-T
M4BNOJIS7SQN/J:LVVI7EHX>WN98R.FUJF>4+[$OO+I\02O\ O(?<_P#,^@:*
M\ITGXBZA:E4OE%U'W;H_YUZ%H^OV&MP[[68;_P"*-N&'X5Y=?!U:&LEIW/<P
MN8X?$Z0=GV>YJ4445R'H",P52S$ #J356+5+">7RHKR!Y/[JN":X7XCZU/%-
M#ID+LB%1))M.-V>@_2O/(Y9(I Z,58'.0<&O7PV6^UIJ<I6OL?/8S.E0K.E&
M-[;GT117.^"]7EU?0E>X.Z:)BC-Z^E=%7F5*;IS<'NCW*-6-:FJD=F%%%%9F
MH4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4UW2-"[L%4<DDX IU>7?$36KA]4&G1N5@B4%@I^\Q]:Z<-AW7J<B=CB
MQN+CA:3J-7/1H-3L;J3RX+N&1_[JN":MU\\13R02"2)V1QT*G!KVWPKJCZMH
M,%Q+@RCY'([D=ZZL9@/J\5).Z.++LT^MR<)1L]S:HHHKS#V@HHHH **** "B
MBB@ HHHH *QO%=N]UX9O8D^]LW#\#FM"^U"UTVV:XNYEBC'<GK]*\Q\2>/+C
M4@]K8 P6QX+?Q./Z"NW!X>K4J*4%HGN>;F&+HT:4H5'JT].IA^&+M+'Q)932
M'""3#'V->Y]17SJ"00PZBO5?!OC"&^M8["^D$=S&,*[' D'^->IFF'E-*K'I
MN>'D>,A3;H3=KZK_ ".UHHZT5\\?7!7CWC^\2Z\3RHAR(5$9^O>N]\4>*[;0
M[5XHG62]885 <[?<UY/9VUSK>K)$-SS3ORW7KU)KW,LH.+=>>BL?,9WBHS2P
MU/5WU_1&G8^%;F]LHKE$8K(,C%%>P6%E%I]A!:1* D2!116,LTJ<SY=CHADE
M'E7-N6:0D $DX ZDTM<#X]\4?9T;2;.3]XP_?,IY4?W:X*%"5::A$]7%8F&&
MI.I/_AV5_%OCH[WL-*? &5DG'?V7_&O/?WD\O\3NQ^I)IUO!+=3I#$A>1S@
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M&?K4/BGQ'-KU^3DK;1G$2?U^M8%?3X+ QI)3FO>_(^*S/-)5Y.G2=H?G_P
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M3^E>UV3![&W9>AC4C\J\M^(>E-9ZU]M4'R[D9S_M#K_2NK\!Z['J&DK92/\
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MH:[LT_@?-'EY%_O7R9UM%%%?,'VX4444 %%%% !1110 4444 %%%% !1110
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H>T%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
